FGF-2 was the first angiogenic factor shown to improve walking performance in PAD patients15 and Sendai virus-expressed FGF-2 demonstrated excellent limb-salvaging effects compared with other factors and vectors11, 12. Here, FGF2 is linked to peripheral arterial disease.